Update on the antitumor activity of alpha interferon
Quesda, J.R.
Oncology 2(3): 49-54
1988
ISSN/ISBN: 0890-9091 PMID: 3079324 Document Number: 311344
Alpha interferons have shown significant antitumor activity against B-cell malignancies (especially hairy cell leukemia), and chronic myelogenous leukemia. They are also useful against malignant carcinoid tumors, renal cell carcinoma, and Kaposi's sarcoma. Alpha interferons are less effective against lung, liver, ovary, breast, and colon carcinoma. Side effects vary in severity according to type of interferon, route of administration, schedule, and dose. In general, tolerance and compliance are excellent with doses of one to nine million units per day.
Document emailed within 1 workday
Related Documents
Haraguchi, S.; Koide, Y.; Matsuo, T.; Yoshida, T.O. 1986: Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(11): 3236-3243Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Kase, S.; Kubota, T.; Watanabe, M.; Furukawa, T.; Tanino, H.; Kuo, T.H.; Saikawa, Y.; Teramoto, T.; Kitajima, M. 1995: Recombinant human interferon alpha-2a increases the antitumor activity of 5-fluorouracil on human colon carcinoma xenograft Co-4 without any change in 5-FU pharmacokinetics Anticancer Research 15(1): 153-155
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Pai, L.H.; Gallo, M.G.; FitzGerald, D.J.; Pastan, I. 1991: Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40) Cancer Research 51(11): 2808-2812
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Trandafir, L.; Ruffié, P.; Borel, C.; Monnet, I.; Soulié, P.; Adams, D.; Cvitkovic, E.; Armand, J.P. 1997: Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma European Journal of Cancer 33(11): 1900-1902
Imam, H.; Gobl, A.; Eriksson, B.; Oberg, K. 1997: Interferon-alpha induces bcl-2 proto-oncogene in patients with neuroendocrine gut tumor responding to its antitumor action Anticancer Research 17(6d): 4659-4665
Geng, Y.; Biffi, A.; Engelstein, D.; Ronch, E.; Faustini, M.; Lai, H.K.; Albino, A.P.; Di Fronzo, G.; Nanus, D.M. 1998: Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas Anticancer Research 18(1a): 1-7
Van Moorselaar, R.J.; Hendriks, B.T.; van Stratum, P.; van der Meide, P.H.; Debruyne, F.M.; Schalken, J.A. 1991: Synergistic antitumor effects of rat gamma-interferon and human tumor necrosis factor alpha against androgen-dependent and -independent rat prostatic tumors Cancer Research 51(9): 2329-2334
Onishi, T.; Machida, T. 1994: A study on direct antitumor activity of bropirimine (oral interferon inducer) for renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 40(3): 195-200
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Fleischmann, W.R.; Kleyn, K.M.; Baron, S. 1980: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations Journal of the National Cancer Institute 65(5): 963-966
Ozaki, S.; Nagase, T.; Ahmad, S.; Tamai, H.; Hoshi, A.; Iigo, M. 1987: Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives Nucleic Acids Symposium Series 18: 1-4
Garbin, F.; Eckert, K.; Büttner, P.; Garbe, C.; Maurer, H.R. 1994: Prothymosin alpha augments deficient antitumor activity of monocytes from melanoma patients in vitro Anticancer Research 14(6b): 2405-2411
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Furukawa, Y.; Iwase, S. 1997: Antileukemic effect of interferon-alpha is mediated through down-modulation of E2F activity Leukemia 11(Suppl 3): 446-448
Yamamoto, K.; Mizutani, Y.; Nakanishi, H.; Fujiwara, J.; Ishida, H.; Toiyama, D.; Abe, K.; Hayashi, I.; Okada, K.; Kawauchi, A.; Mizuno, M.; Yoshida, J.; Miki, T. 2008: Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma International Journal of Oncology 33(3): 565-571
Isogai, E.; Suzuki, N. 1994: Involvement of antipain-sensitive protease activity in suppression of UV-mutagenicity by human interferon-alpha Mutation Research 325(2-3): 81-85
Vasilenko, R.N.; Denisov, L.A.; Galaktionov, V.G. 1989: Effect of recombinant human alpha-interferon (reaferon) on macrophage functional activity in mice Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 100-104